The House passed legislation Tuesday reauthorizing two “critical” federal grant programs that could funnel hundreds of ...

A team of Green Level High School students created an app to find bone cancer and now they're in the running to win a ...

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

The Motley Fool reports that in 2026, Gen Z and millennials focus on AI stocks and view dividend investing as a side hustle, ...

A Baylor University Honors College student is helping advance research aimed at improving heart transplantation outcomes by studying how donor hearts can be better preserved after circulatory death.

DYNAMIKA™ delivers SOC 2 Type II–certified, AI‑driven imaging workflows, giving pharma and biotech secure, compliant ...

The MSU Plant Biology Teaching Conservatory and Greenhouse is a facility designed to showcase a wide botanical collection to ...

When looking only at the past 12 months, Editas Medicine (EDIT 3.15%), a small-cap biotech company, seems to be doing well.

Aarvik Therapeutics , an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer ther ...

BioVie is eyeing a $19.7 million IPO for a spinout focused on bringing a new formulation of an approved kidney failure drug ...

Praxis Precision Medicines develops clinical-stage therapies for neurological disorders, targeting major unmet needs in CNS ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an ...